A recent study conducted in Pittsburgh, Pennsylvania, reveals a substantial reduction in hepatitis B infection rates among newborns. The study examined the impact of routine immunization at birth, demonstrating a 68% decrease in infection within the first ten years. Researchers found that the vaccine significantly lessened the likelihood of developing hepatitis B, a liver infection. This finding strengthens existing evidence regarding the efficacy of the hepatitis B vaccine in protecting infants. The results suggest a valuable tool for improving infant health outcomes.
Credits: NYT > Top Stories